Skip to content
10-Q

Quarterly Report

Glucose Health, Inc. GLUC

0001477932-16-014204

← back to feed
Filed
Dec 21, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Dec 21, 2016 3.31M sh
Stockholders Equity Q3 2016 · Sep 30, 2016 −$373.63K
Stockholders Equity Q3 2016 · Dec 31, 2015 −$387.82K
Current Liabilities Q3 2016 · Sep 30, 2016 $417.59K
Current Liabilities Q3 2016 · Dec 31, 2015 $403.23K
Total Liabilities Q3 2016 · Sep 30, 2016 $417.59K
Total Liabilities Q3 2016 · Dec 31, 2015 $403.23K
Current Assets Q3 2016 · Sep 30, 2016 $43.66K
Current Assets Q3 2016 · Dec 31, 2015 $15.11K
Total Assets Q3 2016 · Sep 30, 2016 $43.96K
Total Assets Q3 2016 · Dec 31, 2015 $15.41K
Operating Cash Flow Q3 2016 · Sep 30, 2015 −$106.54K
Eps Basic Q3 2016 · Sep 30, 2015 −$0.02
Eps Basic Q3 2016 · Sep 30, 2015 −$0.12
Sga Expense Q3 2016 · Sep 30, 2015 $23.17K
Sga Expense Q3 2016 · Sep 30, 2015 $35.65K
Net Income Q3 2016 · Sep 30, 2015 −$49.25K
Net Income Q3 2016 · Sep 30, 2015 −$219.27K
Operating Income Q3 2016 · Sep 30, 2015 −$34.17K
Operating Income Q3 2016 · Sep 30, 2015 −$141.26K
Gross Profit Q3 2016 · Sep 30, 2015 $105
Gross Profit Q3 2016 · Sep 30, 2015 $342
Cost Of Revenue Q3 2016 · Sep 30, 2015 $1.95K
Cost Of Revenue Q3 2016 · Sep 30, 2015 $2.29K
Cash And Equivalents Q3 2016 · Dec 31, 2014 $4.87K